METTL3 and hepatocellular carcinoma: Downregulation of METTL3 cooperates with the 2-deoxyglucose (2-DG) to inhibit HCC proliferation, suggesting that suppressing glycolysis by inhibiting METTL3 might be a potential strategy for treating HCC (Lin et al., 2020).